Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arvind V. Kumbhar"'
Autor:
Mayur P. Shinde, Praveenkumar T. Patil, Mamta S. Rathod, Arvind V. Kumbhar, Mayur P. Pawar, Nimish R. Halasawadekar
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :2438-2443
Background: Antiretroviral drug therapy (ART) has brought a ray of hope to people living with HIV/AIDS. Adverse drug reactions (ADRs) can often cause significant morbidity among individuals on ART, occasionally leading to mortality. The present study
Autor:
Ruchi Doongarshi Shah, Praveenkumar T. Patil, Sunita J. Ramanand, Nimish R. Halasawadekar, Jaiprakash B. Ramanand, Arvind V. Kumbhar, Girish T. Raparti
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :105-111
Background: Polycystic ovary syndrome (PCOS), in addition to impaired ovulation, also affects metabolic pathways. Dyslipidemia, occurring in PCOS women leads to cardiovascular diseases in them. The purpose of the present study was to compare lipid pr
Autor:
Praveen T. Patil, Sunita J. Ramanand, Arvind V. Kumbhar, Ruchi Doongarshi Shah, Arundhati Tukaram Salunke, Nimish R. Halasawadekar, Jaiprakash B. Ramanand
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 7:1572
Background: Presently drug utilization studies (DUS) are in an evolving era. Current literature search has shown paucity of epidemiological studies in the field of paediatric pharmacology. Hence the present study was designed to assess the drug utili
Autor:
Sachin M. Patankar, Sunita J. Ramanand, Rohit N. Herekar, Shraddha M. Pore, Praveeenkumar T. Patil, Ruchi Doongarshi Shah, Arvind V. Kumbhar
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 6:1472
Background: The only effective measure to prevent or reverse most of the manifestations of venomous snake-bite is timely administration of antisnake venom (ASV) with or without adjunctive treatment as necessary in each case. But recently several conc
Autor:
Mayur P. Shinde, Sunita J. Ramanand, Arvind V. Kumbhar, Shraddha M. Pore, Jayprakash B. Ramanand, Praveenkumar T. Patil, Nimish R. Halasawadekar
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 6:354
Background: A high frequency of adverse drug reactions (ADRs) is one of the major challenges in the treatment of Multi-drug resistant tuberculosis (MDR-TB). Patients may refuse to continue treatment if ADRs are not properly addressed, drugs may be st